Century Therapeutics, Inc.
IPSC
$1.92
-$0.01-0.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.17% | -128.27% | 46.85% | -10.26% | -4.27% |
| Total Depreciation and Amortization | -18.31% | -6.74% | 6.99% | -5.12% | -7.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 365.50% | -109.51% | -153.92% | 174.80% | 917.33% |
| Change in Net Operating Assets | 197.59% | 94.45% | 72.57% | 71.35% | -198.74% |
| Cash from Operations | 28.12% | 27.04% | 33.63% | 9.70% | -0.95% |
| Capital Expenditure | -118.93% | -22.95% | 190.26% | -124.25% | -19.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.99% | -494.41% | -27.81% | -35.20% | 236.95% |
| Cash from Investing | -45.40% | -503.20% | -26.94% | -37.06% | 196.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 105,419.17% | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 105,419.17% | 108.80% | -100.00% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -135.50% | -71.22% | 9.62% | -108.20% | 209.96% |